×
About 68,266 results

ALLMedicine Cardiomyopathy Center

Research & Reviews  32,585 results

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo.
https://doi.org/10.3791/61158
Journal of Visualized Experiments : JoVE; Liu Y, Zhang W et. al.

Jun 1st, 2020 - Dilated cardiomyopathy (DCM) refers to a spectrum of heterogeneous myocardial disorders characterized by ventricular dilation and depressed cardiac performance in the absence of hypertension, valvular, congenital, or ischemic heart diseases, and w...

Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol.
https://doi.org/10.1161/CIRCHEARTFAILURE.120.007000
Circulation. Heart Failure; Caravita S, Baratto C et. al.

Jun 1st, 2020 - Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol.|2020|Caravita S,Baratto C,Perego GB,Cecchi F,Crotti L,|

Characterization of interstitial diffuse fibrosis patterns using texture analysis of my...
https://doi.org/10.1371/journal.pone.0233694
PloS One; El-Rewaidy H, Neisius U et. al.

Jun 1st, 2020 - The pattern of myocardial fibrosis differs significantly between different cardiomyopathies. Fibrosis in hypertrophic cardiomyopathy (HCM) is characteristically as patchy and regional but in dilated cardiomyopathy (DCM) as diffuse and global. We s...

Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in...
https://doi.org/10.1016/j.ahj.2020.03.023
American Heart Journal; Herkert JC, Verhagen JMA et. al.

Jun 1st, 2020 - Biallelic damaging variants in ALPK3, encoding alpha-protein kinase 3, cause pediatric-onset cardiomyopathy with manifestations that are incompletely defined. We analyzed clinical manifestations of damaging biallelic ALPK3 variants in 19 pediatric...

Predictors of subcutaneous ICD shocks and prognostic impact in patients with structural...
https://doi.org/10.1016/j.cjca.2020.05.032
The Canadian Journal of Cardiology; Ninni S, Echivard M et. al.

May 31st, 2020 - We aimed to assess long-term outcomes in S-ICD recipients with structural heart disease, especially focusing on shock incidence, predictors and associated prognoses. In this multicenter registry-based study, we retrospectively included all patient...

see more →

Guidelines  31 results

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy
https://jamanetwork.com/journals/jamacardiology/fullarticle/2733139

May 21st, 2019 - Question Is it possible to identify most patients with hypertrophic cardiomyopathy (HCM) at risk of arrhythmic sudden cardiac death (SCD) and to prevent such events with prophylactic implantable cardioverter/defibrillators (ICDs)? Findings In t...

Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific ...
https://www.ahajournals.org/doi/10.1161/CIR.0000000000000599
Nunes, M.

Aug 19th, 2018 - Chagas disease, resulting from the protozoan Trypanosoma cruzi, is an important cause of heart failure, stroke, arrhythmia, and sudden death. Traditionally regarded as a tropical disease found only in Central America and South America, Chagas dise.

Genetic evaluation of cardiomyopathy: a clinical practice resource of the American Coll...
https://doi.org/10.1038/s41436-018-0039-z
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Hershberger RE, Givertz MM et. al.

Jun 15th, 2018 - The purpose of this document is to provide updated guidance for the genetic evaluation of cardiomyopathy and for an approach to manage secondary findings from cardiomyopathy genes. The genetic bases of the primary cardiomyopathies (dilated, hypert...

Recommendations for Multimodality CardiacImaging in Patients with Chagas Disease: A Reportfr...
http://asecho.org/wordpress/wp-content/uploads/2018/01/2018_Chagas.pdf
Acquatella, H.

Dec 31st, 2017 - Chagas disease (ChD) is a significant public health problem in mostLatin American countries. Observed mainly in rural areas, in recentdecades it has spread to cities and to nonendemic countries, mostlyas a result of migration of infected people.

Cardiac Effects of Lightning Strikes
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610732/
Arrhythmia & Electrophysiology Review; Christophides,T.,et al

Jul 31st, 2017 - Lightning strikes are a common and leading cause of morbidity and mortality. Multiple organ systems can be involved, though the effects of the electrical current on the cardiovascular system are one of the main modes leading to cardiorespiratory a...

see more →

Drugs  41 results see all →

Clinicaltrials.gov  33,981 results

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo.
https://doi.org/10.3791/61158
Journal of Visualized Experiments : JoVE; Liu Y, Zhang W et. al.

Jun 1st, 2020 - Dilated cardiomyopathy (DCM) refers to a spectrum of heterogeneous myocardial disorders characterized by ventricular dilation and depressed cardiac performance in the absence of hypertension, valvular, congenital, or ischemic heart diseases, and w...

Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol.
https://doi.org/10.1161/CIRCHEARTFAILURE.120.007000
Circulation. Heart Failure; Caravita S, Baratto C et. al.

Jun 1st, 2020 - Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol.|2020|Caravita S,Baratto C,Perego GB,Cecchi F,Crotti L,|

Characterization of interstitial diffuse fibrosis patterns using texture analysis of my...
https://doi.org/10.1371/journal.pone.0233694
PloS One; El-Rewaidy H, Neisius U et. al.

Jun 1st, 2020 - The pattern of myocardial fibrosis differs significantly between different cardiomyopathies. Fibrosis in hypertrophic cardiomyopathy (HCM) is characteristically as patchy and regional but in dilated cardiomyopathy (DCM) as diffuse and global. We s...

Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in...
https://doi.org/10.1016/j.ahj.2020.03.023
American Heart Journal; Herkert JC, Verhagen JMA et. al.

Jun 1st, 2020 - Biallelic damaging variants in ALPK3, encoding alpha-protein kinase 3, cause pediatric-onset cardiomyopathy with manifestations that are incompletely defined. We analyzed clinical manifestations of damaging biallelic ALPK3 variants in 19 pediatric...

Predictors of subcutaneous ICD shocks and prognostic impact in patients with structural...
https://doi.org/10.1016/j.cjca.2020.05.032
The Canadian Journal of Cardiology; Ninni S, Echivard M et. al.

May 31st, 2020 - We aimed to assess long-term outcomes in S-ICD recipients with structural heart disease, especially focusing on shock incidence, predictors and associated prognoses. In this multicenter registry-based study, we retrospectively included all patient...

see more →

News  1,543 results

Mavacamten Phase 2 Results Hopeful in Nonobstructive Hypertrophic Cardiomyopathy
https://www.medscape.com/viewarticle/931112

May 25th, 2020 - An investigational, first-in-class agent showed hypothesis-generating promise in symptomatic adults with nonobstructive hypertrophic cardiomyopathy (HCM), a condition lacking in good treatment options, in an early dose-finding study. The 40 patien...

Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to Know
https://www.medscape.com/viewarticle/930827

May 21st, 2020 - Hypertrophic cardiomyopathy (HCM) is the most common inherited monogenic cardiac disorder, affecting 0.2-0.5% of the population.[1,2] In the United States, 750,000 people are estimated to have HCM; however, only approximately 100,000 people have b...

SGLT2 Inhibitor Therapy Could Curb Heart Failure Deaths
https://www.medscape.com/viewarticle/930517

May 14th, 2020 - NEW YORK (Reuters Health) — According to projections from a decision-analytical model, sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy could be of great benefit in certain patients with heart failure. The findings show "that the addition...

Fast Five Quiz: Acute Heart Failure Presentation and Diagnosis
https://www.medscape.com/viewarticle/925289

May 11th, 2020 - Acute heart failure is characterized by rapid onset or deterioration of symptoms and/or signs of heart failure, frequently with decompensation of preexisting cardiomyopathy. It is a life-threatening medical emergency. Globally, both in-hospital an...

Functional Gains From Novel Agent for Obstructive HCM, Top-line Results
https://www.medscape.com/viewarticle/930383

May 11th, 2020 - Patients with obstructive hypertrophic cardiomyopathy (HCM) who took an investigational agent that targets cardiac myosin over about 7 months showed across-the-board improvements in functional capacity, symptoms, and left ventricular outflow obstr...

see more →

Patient Education  85 results see all →